This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
IN OCTOBER 1994, the Advisory Committee on Immunization Practices (ACIP) approved recommendations expanding the vaccination strategy to eliminate hepatitis B virus (HBV) transmission in the United States. These recommendations include:
Vaccination of all unvaccinated children aged <11 years who are Pacific Islanders or who reside in households of first-generation immigrants from countries where HBV is of high or intermediate endemicity.
Vaccination of all 11-12-year-old children who have not previously received hepatitis B vaccine.
Reported by: Epidemiology and Surveillance Div, National Immunization Program; Hepatitis Br, Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC.
CDC Editorial Note:
In November 1991, the ACIP recommended that hepatitis B vaccine be integrated into infant vaccination schedules.1 However, high rates of HBV infection continue to occur among children aged 0-10 years who are Alaskan Natives, Pacific Islanders, and infants of first-generation immigrant mothers from areas where HBV infection
Update: Recommendations to Prevent Hepatitis B Virus Transmission—United States. JAMA. 1995;274(8):603-604. doi:10.1001/jama.1995.03530080019016